In last trading session, Traws Pharma Inc (NASDAQ:TRAW) saw 78522.0 shares changing hands with its beta currently measuring 0.91. Company’s recent per share price level of $8.07 trading at -$0.96 or -10.63% at ring of the bell on the day assigns it a market valuation of $29.32M. That closing price of TRAW’s stock is at a discount of -147.09% from its 52-week high price of $19.94 and is indicating a premium of 49.69% from its 52-week low price of $4.06. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.21 million shares which gives us an average trading volume of 517.34K if we extend that period to 3-months.

Traws Pharma Inc (NASDAQ:TRAW) trade information

Upright in the red during last session for losing -10.63%, in the last five days TRAW remained trading in the red while hitting it’s week-highest on Tuesday, 01/07/25 when the stock touched $8.07 price level, adding 15.14% to its value on the day. Traws Pharma Inc’s shares saw a change of -9.12% in year-to-date performance and have moved -9.12% in past 5-day. Traws Pharma Inc (NASDAQ:TRAW) showed a performance of 69.18% in past 30-days. Number of shares sold short was 7389.0 shares which calculate 0.62 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 58.67% during past 5 years.